Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CBR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OPTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAMPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL15RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNF4G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101926887 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN3A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ERAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYCBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAPP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM140 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC41A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDXK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUNX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on